Investigators from Cedars-Sinai and the University of California, San Francisco (UCSF) have identified a new way to deliver ...

J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...

With nearly 90% of patients showing no detectable cancer cells after treatment, J&J and Legend’s Carvykti could stave off ...

In this manuscript, Yao et al. present solid evidence to show that MnMYL3 may serve as a receptor for NNV via macropinocytosis. This manuscript is valuable for understanding the molecular mechanisms ...

Noting that recent advances in artificial intelligence and the existence of large-scale experimental data about human biology ...

This paper presents the important discovery that lipid metabolic imbalance caused by Snail, an EMT-related transcription factor, contributes to the acquisition of chemoresistance in cancer cells.

The US regulator has turned down J&J's marketing application for a subcutaneous (SC) formulation of EGFRxMET bispecific ...

A Stanford-led team discovered a new ketosis pathway involving BHB-amino acids, shedding light on its effects like appetite ...

A research team has achieved a significant breakthrough in clean energy technology. The team has successfully enhanced a ...

Diabetes researchers and bioinformaticians from the Icahn School of Medicine at Mount Sinai have developed a new ...